Quick Answer
LEMAITRE VASCULAR INC reported Diluted EPS of $2.52 per share for fiscal year 2025.
LEMAITRE VASCULAR INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $2.52 | +30.6% |
| 2024 | $1.93 | +44.0% |
| 2023 | $1.34 | +44.1% |
| 2022 | $0.93 | -25.6% |
| 2021 | $1.25 | +20.2% |
| 2020 | $1.04 | +18.2% |
| 2019 | $0.88 | -22.1% |
| 2018 | $1.13 | +31.4% |
| 2017 | $0.86 | +56.4% |
| 2016 | $0.55 | +31.0% |
| 2015 | $0.42 | +82.6% |
| 2014 | $0.23 | +15.0% |
| 2013 | $0.20 | +25.0% |
| 2012 | $0.16 | +23.1% |
| 2011 | $0.13 | -64.9% |
| 2010 | $0.37 | +270.0% |
| 2009 | $0.10 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.75 | +53.1% | +25.0% |
| June 30, 2025 | $0.60 | +15.4% | +25.0% |
| March 31, 2025 | $0.48 | +9.1% | -2.0% |
| September 30, 2024 | $0.49 | +48.5% | -5.8% |
| June 30, 2024 | $0.52 | +44.4% | +18.2% |
| March 31, 2024 | $0.44 | +63.0% | +33.3% |
| September 30, 2023 | $0.33 | +32.0% | -8.3% |
| June 30, 2023 | $0.36 | +125.0% | +33.3% |
- LEMAITRE VASCULAR INC showed an increase of +30.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, LEMAITRE VASCULAR INC’s diluted eps has grown by 2420.0% (from $0.10 per share to $2.52 per share).
- The most recent figure is from LEMAITRE VASCULAR INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: